Sarepta Therapeutics Inc (SRPT)
Healthcare
Biotechnology
15.90 $
+6.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -203 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -122 | -115 | -55 | -242 | 15 | -71 | 92 | -583 | 261 | -15 | 131 | -203 | 175 | |
| 11 | 11 | 11 | 8.7 | 8.7 | 9.8 | 10 | 10.0 | 11 | 18 | 5.3 | 11 | 45 | |
| 47 | 48 | 46 | 41 | 50 | 43 | 50 | 41 | 37 | 15 | 30 | 29 | 111 | |
| -47 | -155 | -150 | -330 | -45 | -217 | -125 | -282 | 50 | -29 | 340 | -586 | -226 | |
| 18 | 41 | 19 | 42 | 29 | 37 | 38 | 46 | 32 | 28 | 5.8 | 3.1 | 69 | |
| 97 | -211 | -64 | 219 | -99 | -129 | 764 | -291 | 32 | 232 | 96 | -134 | 226 | |
| – | – | – | – | – | – | – | – | -25 | 0.0 | 0.0 | – | – | |
| – | – | – | – | – | – | – | -3.2 | -0.3 | -124 | -35 | 0.0 | -159 | |
| 5.9 | 15 | 1.9 | 22 | 40 | 14 | 49 | 12 | -24 | -118 | -39 | 0.2 | -181 | |
| -20 | -310 | -117 | -1.1 | -44 | -186 | 905 | -862 | 270 | 100 | 188 | -337 | 221 | |
| -140 | -155 | -74 | -285 | -14 | -108 | 54 | -629 | 229 | -43 | 125 | -206 | 106 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.